Sang Thrombose Vaisseaux
MENUCardiovascular toxicity related to anthracylines. What screening strategy in 2022? Volume 34, issue 3, May-June 2022
Authors
Hôpital privé d’Antony, cardiologie, 25, rue de la providence, 92160 Antony, France
* Tirés à part : E. Alonso
- Key words: cardiotoxicity, anthracyclines, global longitudinal strain
- DOI : 10.1684/stv.2022.1208
- Page(s) : 119-23
- Published in: 2022
Cardiovascular complications in cancer patients present a growing medical problem with high morbidity and premature mortality in this population.
Current prevention strategies include use of less cardiotoxic cancer treatment regimens, cardiovascular risk factor management, and initiation of cardio-protective therapy (CPT), either in all patients or guided by surveillance of cardiac function.